Search by Drug Name or NDC
NDC 50090-5868-00 Clopidogrel 75 mg/1 Details
Clopidogrel 75 mg/1
Clopidogrel is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is CLOPIDOGREL BISULFATE.
MedlinePlus Drug Summary
Clopidogrel is used alone or with aspirin to prevent serious or life-threatening problems with the heart and blood vessels in people who have had a stroke, heart attack, or severe chest pain. This includes people who have percutaneous coronary intervention (PCI; angioplasty; a type of heart surgery) that may involve inserting coronary stents (metal tubes surgically placed in clogged blood vessels to improve blood flow) or who have coronary artery bypass grafting (CABG; a type of heart surgery). Clopidogrel is also used to prevent serious or life-threatening problems with the heart and blood vessels in people who have peripheral arterial disease (poor circulation in the blood vessels that supply blood to the legs). Clopidogrel is in a class of medications called antiplatelet medications. It works by preventing platelets (a type of blood cell) from collecting and forming clots that may cause a heart attack or stroke.
Related Packages: 50090-5868-00Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Clopidogrel
Product Information
| NDC | 50090-5868 |
|---|---|
| Product ID | 50090-5868_8ed73a37-390b-4cc9-a0b4-093637038100 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Clopidogrel |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clopidogrel Bisulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLOPIDOGREL BISULFATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090540 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-5868-00 (50090586800)
| NDC Package Code | 50090-5868-0 |
|---|---|
| Billing NDC | 50090586800 |
| Package | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5868-0) |
| Marketing Start Date | 2021-12-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |